demonstrated that TMAO could trigger the activation of the nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome and inhibit the autophagy gene ATG16L1-induced autophagy to promote the progression of inflammatory bowel disease (IBD) (69). This evidence concerns the gene NLRP3 and inflammatory bowel disease.